IL-17A在大鼠房颤模型中的作用和机制研究
[Abstract]:Background Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice. In recent years, a new helper T cell subset-Th17 (Th17) and its specific effector interleukin-17 (IL-17) have attracted much attention. IL-17 has been proved to be an important inflammatory mediator in many cardiovascular diseases. Interleukin-17 (IL-17) plays an important role in the development of atrial fibrillation, including atherosclerosis, chronic heart failure, acute coronary syndrome and viral myocarditis. Phase I matched case-control study showed that IL-17A in peripheral plasma was associated with AF, and with the increase of factor levels, the stronger the association was, and it may affect AF by affecting cardiac structural remodeling. However, the specific role and mechanism of IL-17A in the occurrence and maintenance of AF, and the role of IL-17A in peripheral blood and atrial tissue were also discussed. Objective To explore the relationship between IL-17 and atrial fibrillation in SD rats by rapid esophageal atrial pacing, and to analyze the consistency of IL-17A level in peripheral blood with atrial tissue and the relationship between them and atrial fibrosis. The correlation between IL-17A and matrix metalloproteinase (MMP) and tissue inhibitor metalloproteinase (TIMP) was analyzed to further validate the mechanism of IL-17A inducing atrial fibrosis by inducing imbalance of MMPs/TIMPs. Methods 1. A rat model of atrial fibrillation was established by transesophageal rapid atrial pacing, and the changes of electrocardiogram data, including QRS, were compared and analyzed between atrial fibrillation group and control group. The changes of plasma levels of IL-17A and C-reactive protein (CRP) and plasma levels of MMP2, MMP9 and TIMP 2 in AF group and control group were measured by enzyme-linked immunosorbent assay. 3. The levels of IL-17A, MMP2 and MMP in atrial tissues were determined by immunohistochemistry. Pearson correlation analysis was used to analyze the consistency of IL-17A in plasma and atrial tissues and their correlation with atrial fibrosis. The consistency of MMP2, MMP9, TIMP2 in plasma and atrial tissues and their correlation with atrial fibrosis were also analyzed. Result The first chapter was the establishment of rat atrial fibrillation model. 1. The heart rate of rats in AF group increased significantly from (159.63 (+ 18.25) beats per minute in normal time to (203.24 (+ 33.56) beats per minute in AF attack. Meanwhile, the QRS interval and QT interval prolonged significantly from 50.00 (+ 4.28 ms), 103.00 (+ 1.85 ms) to 68.85 (+ 14.73 ms) and 134.80 (+ 22.05) beats in normal time, respectively. The degree of atrial fibrosis in AF group was more serious than that in control group. The volume fraction of collagen in AF group was significantly higher than that in control group [(18.15+9.45)% vs (6.51+4.49)%, P 0.01]. The level of IL-17A in atrial tissue of AF group was significantly higher than that of control group (0.17.05 vs 0.04.01, P = 0.003). 3. The level of IL-17A in plasma of AF group was significantly higher than that of control group (0.17.05 vs 0.04.01, P = 0.003). The level of IL-17A in plasma was positively correlated with atrial fibrosis (r = 0.830, P = 0.003), and the level of IL-17A in atrial tissue was positively correlated with atrial fibrosis (r = 0.685, P = 0.029). Compared with the control group, the levels of MMP 2 and MMP 9 in atrial tissue of AF group were significantly higher (0.12.05 vs 0.04.02, P = 0.021; 0.08.01 vs 0.03.01, P 0.001), while the levels of TIMP 2 were significantly lower in AF group (0.02.00 vs 0.06.02, P = 0.004). The levels of MMP 2, MMP 9 and TIMP 2 in atrial tissues were positively correlated with atrial fibrosis (r = 0.809, P = 0.005). The levels of TIMP 2 were negatively correlated with atrial fibrosis (r = - 0.884, P = 0.001). No correlation was found between the levels of MMP 2 in atrial tissues and atrial fibrosis (r = 0.599, P = 0.067). 4. The levels of MMP-9 in plasma were positively correlated with IL-17A (r = 0.648, P = 0.043), and TIMP-2 was negatively correlated with IL-17A (r =-0.695, P = 0.037). No correlation was found between the levels of MMP-2 and IL-17A (r = 0.576, P = 0.082). MMP-2, MMP-9 and IL-17A were positively correlated in atrial tissues of AF rats (r = 0.801, P = 0.005; r = 0.778, P = 0.008). Conclusion IL-17A is closely related to the occurrence and development of atrial fibrillation in the rat model of atrial fibrillation. IL-17A may induce atrial remodeling by affecting the balance of MMPs/TIMPs, leading to the occurrence and development of atrial fibrillation.
【学位授予单位】:第三军医大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R541.75;R-332
【参考文献】
相关期刊论文 前10条
1 何金辉;;孤立性心房颤动患者血清CRP、IL8和IL10水平的变化[J];中西医结合心脑血管病杂志;2014年10期
2 朱宝龙;徐方芳;;肌钙蛋白T、中介素等因子在大鼠房颤模型中的变化及意义[J];宁夏医科大学学报;2014年06期
3 官莉;宫原;陈世雄;;IL-17生物学效应与临床研究进展[J];现代免疫学;2014年02期
4 戴天医;罗太阳;何怡华;谷孝艳;汤日波;董建增;刘小慧;;犬房颤模型心房纤维化对心房重塑和炎症水平的影响[J];第三军医大学学报;2013年22期
5 陈唐葶;李涛;李妙龄;刘智飞;杨艳;曾晓荣;;心房快速起搏致豚鼠房颤模型建立及心房肌动作电位的改变[J];泸州医学院学报;2012年06期
6 兰法定;;心房颤动患者血清C反应蛋白的变化及意义[J];中国实用医药;2011年35期
7 孙冰;刘和平;安佰富;张广成;;心房颤动患者高敏C反应蛋白水平的变化及临床意义[J];中国老年学杂志;2011年23期
8 罗助荣;张克己;林毅;郑磊磊;徐高阳;盖晓波;;ACS血清OPG、sRANKL与hs-CRP及冠状动脉病变程度的相关性研究[J];临床心血管病杂志;2011年07期
9 戴小波;孙万邦;;IL-17免疫调节作用的研究进展[J];检验医学与临床;2011年06期
10 张荣君;李源;黄卫斌;;心房纤颤动物模型制作方法现状及展望[J];实用心脑肺血管病杂志;2010年11期
相关硕士学位论文 前1条
1 刘媛;炎症因子与房颤的相关性研究[D];第三军医大学;2016年
,本文编号:2246731
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2246731.html